Sakitamiwa Classification ((full)) May 2026

The Sakita-Miwa classification (originally Sakita et al., 1971) is an endoscopic staging system used to categorize the lifecycle and healing progress of peptic ulcers. It is primarily used in East Asian clinical practice to assess gastric and duodenal ulcers.

The system divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two sub-stages: 1. Active Stage (A) This stage represents the early, acute phase of the ulcer.

A1 (Active-1): The ulcer is at its peak activity. It is characterized by a thick white-plaque coating (slough), discrete margins, and significant surrounding edema.

A2 (Active-2): The edema begins to subside, and the ulcer margins become clearer. The mucus coating remains prominent. 2. Healing Stage (H) In this stage, signs of tissue repair become visible.

H1 (Healing-1): Regenerative epithelium (new skin-like tissue) begins to appear at the edges, making the ulcer shallower. The white coating starts to shrink.

H2 (Healing-2): The regenerative epithelium nearly covers the mucosal break. The ulcer is significantly smaller, and the coating is minimal. 3. Scarring Stage (S) This stage indicates complete or near-complete healing.

S1 (Scar-1 / Red Scar): The mucosal defect has closed. A red, flat scar is visible, representing new, highly vascularized tissue.

S2 (Scar-2 / White Scar): The final stage of healing. The redness disappears, leaving a white, flat scar as fibrous tissue matures and capillary density decreases. Summary Table Clinical Feature Highlights Active Thick white coating, edema, discrete margins Healing Epithelial regeneration, shallower base, shrinking coating Scarring Complete closure; initially red, maturing into a white scar

While the Forrest classification is typically used to assess bleeding risk, the Sakita-Miwa system is preferred for monitoring the quality and rate of healing over time.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Page 1 of 14 - GI Research

This classification system is widely used in Tropical Pediatrics and Infectious Diseases to differentiate between two major types of childhood tuberculosis (TB). It was proposed by Dr. Asril Aminullah and colleagues in Indonesia (sometimes referred to as the "Miwa" classification in local literature derived from Japanese collaborative studies, specifically involving Dr. Miwa).

Here is the full content regarding the Sakit-Miwa Classification, its clinical significance, and application.

Introduction

The goal of any lesion classification is to group entities by shared origin, morphology, natural history, and treatment implications. The Sakitamiwa classification (hypothetical name used here) divides congenital cutaneous and soft-tissue anomalies into four principal categories: Vascular malformations, Vascular tumors, Hamartomas/overgrowth syndromes, and Developmental epidermal/dermal defects. This structure aids clinicians in diagnosis, prognosis, and selecting therapy.

3. Diagnostic Criteria Used in the System

The classification relies on a scoring system (often adapted from the Indonesian Pediatric Society scoring system) which includes:

  1. Contact History: Close contact with an adult with infectious TB.
  2. Clinical Symptoms: Cough > 2 weeks, fever, night sweats, weight loss/failure to thrive.
  3. Tuberculin Skin Test (TST/Mantoux): Positive induration.
  4. Radiological Findings: Chest X-ray abnormalities consistent with TB.
  5. Bacteriological Confirmation: Positive sputum or gastric aspirate (though often negative in children).

How is the Sakitamiwa Classification Applied?

The application process involves a multi-step diagnostic workflow:

  1. Tissue Acquisition: Biopsy or surgical resection specimens are fixed and stained with standard hematoxylin and eosin. For precise grading, special stains (Masson’s trichrome, PAS, or Congo red) are used.
  2. Immunohistochemistry (IHC): The Sakitamiwa system requires scoring of at least three biomarkers, typically Ki-67 (proliferation index), p53 (tumor suppressor status), and CD34 (microvascular density). Each biomarker receives a 0–3 score.
  3. Morphometric Analysis: Using digital pathology software, the pathologist measures the diseased area (mm²), cellular pleomorphism, and mitotic count per high-power field.
  4. Algorithmic Synthesis: The final grade (Sak-N through Sak-D) is derived from a weighted formula combining the morphological grade and IHC score.

10. Implications and next steps

If you want, I can:

The Sakita-Miwa classification is a widely recognized endoscopic system used to stage the life cycle and healing process of peptic ulcers . It divides the ulcer's progression into three main stages—Active, Healing, and Scarring—each containing two sub-stages . Sakita-Miwa Classification Guide Key Endoscopic Characteristics Active (A) A1

Thick white coating (slough/exudate) on the ulcer base; sharp, swollen, or edematous margins . A2

Slough becomes thinner; edema at the margin begins to decrease; the ulcer base is clearly demarcated . Healing (H) H1

Regenerating epithelium (reddish area) appears at the ulcer margin; ulcer becomes shallower . H2

Regenerating epithelium covers most of the ulcer base, leaving only a tiny amount of slough in the center . Scarring (S) S1

Slough completely disappears; the area is covered by red, regenerating epithelium (Red Scar) . S2

The redness fades, and the area becomes white and flat, blending with the surrounding mucosa (White Scar) . Clinical Utility

Understanding the Sakita-Miwa Classification for Peptic Ulcers

The Sakita-Miwa classification is a widely recognized endoscopic system used to evaluate the life cycle and healing progress of peptic ulcers, including gastric and duodenal ulcers. By categorizing ulcers into specific stages, clinicians can standardize the assessment of treatment efficacy, monitor healing quality, and predict the risk of complications like rebleeding. The Three Main Stages and Six Substages

The system divides the ulcer life cycle into three primary stages: Active (A), Healing (H), and Scarring (S). Each stage is further divided into two substages (1 and 2) to provide a granular view of the mucosal defect’s status. 1. Active Stage (A)

This stage represents the acute phase of the ulcer where the mucosal defect is most prominent.

A1 (Active-1): The ulcer is deep, and the base is covered with a thick white or yellowish slough (exudate). The surrounding mucosa is typically red and swollen (edematous).

A2 (Active-2): The edema in the surrounding mucosa begins to subside. The ulcer margin becomes sharper and more clearly defined, though the white coating remains thick. 2. Healing Stage (H)

As treatment progresses, the ulcer enters the healing phase, characterized by the gradual reduction of the slough and the appearance of regenerative tissue. sakitamiwa classification

H1 (Healing-1): A thin white coating remains, but regenerating epithelium (new skin-like lining) begins to appear at the ulcer margins, often forming a "palisade" or star-like pattern as it creeps inward.

H2 (Healing-2): The ulcer becomes significantly shallower and smaller. The regenerative epithelium covers a larger portion of the base, and the white coating is markedly reduced. 3. Scarring Stage (S)

This final stage indicates that the ulcer has closed, though the underlying tissue is still maturing.

Sakitamiwa Classification Report

Introduction

Sakitamiwa is a term used in some African cultures to describe a range of physical and mental health conditions. The classification of Sakitamiwa is not well-established in Western medical literature, and its diagnosis and treatment vary across different cultural contexts. This report aims to provide an overview of the classification of Sakitamiwa, its symptoms, and possible approaches to diagnosis and treatment.

Classification

The classification of Sakitamiwa is not universally agreed upon, and different cultural contexts have their own understanding of the condition. However, based on available literature and research, Sakitamiwa can be broadly classified into the following categories:

  1. Physical symptoms: Sakitamiwa is often characterized by physical symptoms such as body aches, joint pains, headaches, and fatigue.
  2. Mental health symptoms: Sakitamiwa is also associated with mental health symptoms such as anxiety, depression, and stress.
  3. Spiritual symptoms: In some cultural contexts, Sakitamiwa is believed to have spiritual causes, such as possession by evil spirits or ancestral curses.

Sub-classifications

Further sub-classifications of Sakitamiwa have been proposed based on the predominant symptoms:

  1. Type 1: Physical Sakitamiwa: Characterized by physical symptoms such as body aches and joint pains.
  2. Type 2: Mental Sakitamiwa: Characterized by mental health symptoms such as anxiety and depression.
  3. Type 3: Spiritual Sakitamiwa: Characterized by spiritual symptoms such as possession by evil spirits or ancestral curses.

Diagnostic Approaches

The diagnosis of Sakitamiwa is often based on clinical evaluation and cultural context. The following diagnostic approaches may be used:

  1. Clinical evaluation: A thorough medical history and physical examination to rule out other conditions that may present with similar symptoms.
  2. Cultural assessment: An assessment of the patient's cultural background and beliefs to understand the context of the condition.
  3. Questionnaires and interviews: The use of standardized questionnaires and interviews to gather information about the patient's symptoms and experiences.

Treatment Approaches

The treatment of Sakitamiwa varies across different cultural contexts and may include:

  1. Traditional medicine: The use of traditional remedies and therapies, such as herbalism and spiritual healing.
  2. Western medicine: The use of Western medical treatments, such as pharmaceuticals and cognitive-behavioral therapy.
  3. Complementary therapies: The use of complementary therapies, such as acupuncture and massage.

Conclusion

The classification of Sakitamiwa is complex and multifaceted, reflecting the diverse cultural contexts in which it is experienced. A comprehensive understanding of Sakitamiwa requires an appreciation of the physical, mental, and spiritual symptoms, as well as the cultural context in which they occur. Further research is needed to develop more effective diagnostic and treatment approaches for Sakitamiwa.

Recommendations

  1. Cultural sensitivity: Healthcare providers should be culturally sensitive and aware of the cultural context of Sakitamiwa.
  2. Holistic approach: A holistic approach to diagnosis and treatment should be adopted, taking into account the physical, mental, and spiritual aspects of Sakitamiwa.
  3. Further research: Further research is needed to develop more effective diagnostic and treatment approaches for Sakitamiwa.

I’m not familiar with a specific term called “sakitamiwa classification” in any established academic, medical, or taxonomic field. It’s possible this could be:

  1. A misspelling or phonetic variation – For example, similar-sounding terms might include Sakitami (a name or place), sakti/śakti (Sanskrit for power), miwa (a Japanese surname or Shinto term), or Saikami (a Japanese shrine name).

  2. A coined term from fiction, gaming, or online lore – Some fandoms create detailed classification systems (e.g., for creatures, power levels, or character types). If this comes from a manga, novel, or game, providing the source would help.

  3. A niche or non-English academic system – Possibly in fields like traditional medicine, botany, or library science in Japanese or another language.

Could you share where you encountered the term (book, website, class, game)? With a bit more context, I’d be happy to help decode or research it further.

Clinical Report: Sakita-Miwa Classification for Gastric Ulcers 📋 Executive Summary

The Sakita-Miwa classification is a globally recognized endoscopic grading system used to evaluate the life cycle and healing stages of peptic (specifically gastric) ulcers. Developed in Japan, it provides clinicians with a standardized framework to assess whether an ulcer is in an active, healing, or scarring phase. This classification directly informs treatment efficacy and determines the duration of acid-suppressive therapy. 🔬 Classification Breakdown

The system divides the progression of a gastric ulcer into three distinct stages, with each stage further sub-divided into two levels, creating a total of six sequential phases: 1. Active Stage (A)

A1 (Active 1): The ulcer is sharply demarcated with a deep crater. The floor is covered heavily with a thick, white or yellowish-gray exudate (slough). The surrounding mucosal margin is swollen and edematous.

A2 (Active 2): The edema in the surrounding mucosa begins to subside. The ulcer margin becomes clearer, and the depth may appear slightly shallower than in A1. 2. Healing Stage (H)

H1 (Healing 1): A thin white coat of exudate remains at the base, but regenerating epithelium (reddish in color) begins to appear at the margin. The ulcer size noticeably shrinks.

H2 (Healing 2): The ulcer becomes significantly smaller and shallower. The regenerative epithelium covers most of the ulcer base, leaving only a small amount of central white slough. 3. Scarring Stage (S) The Sakita-Miwa classification (originally Sakita et al

S1 (Scarring 1 / Red Scar): The white exudate has completely disappeared. The ulcer is replaced by a flat, red, regenerating mucosal scar, often radiating outward in a star-like pattern.

S2 (Scarring 2 / White Scar): The redness fades over several months. The area turns into a pale, white, flat scar indistinguishable from normal mucosa except for its lack of normal gastric folds. 📊 Summary Table of Stages Core Endoscopic Appearance Active (A) A1

Deep crater, heavy white/gray slough, intense surrounding edema A2 Slough remains, but surrounding mucosal edema subsides Healing (H) H1

Ulcer shrinks; reddish regenerating epithelium appears at the borders H2

Ulcer is very small and shallow; regeneration dominates the floor Scarring (S) S1

Slough gone; replaced by a flat, red, radiating mucosal scar S2

Mature healing; the red scar fades to a stable, pale white scar 💡 Clinical Significance and Application

Treatment Monitoring: Gastroenterologists use the scale to measure how well an ulcer is responding to proton pump inhibitors (PPIs) or potassium-competitive acid blockers (P-CABs). Complete cure is typically defined when an ulcer successfully reaches the S1 or S2 stage.

Bleeding Risk: Ulcers identified in the A1 or A2 stages pose a much higher risk for acute upper gastrointestinal bleeding compared to those in the healing or scarring stages.

Therapeutic Endpoints: Many clinical trials for anti-ulcer medications use the transition from A-stage to S-stage within 4 to 8 weeks as their primary efficacy endpoint.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The Sakita-Miwa classification is a widely used endoscopic staging system for assessing the healing process of gastric ulcers

. It categorizes the lifecycle of an ulcer into six distinct sub-stages across three major phases: ClinicalTrials.gov 1. Active Stage (A)

This stage represents the initial, most severe phase of the ulcer where the lesion is fully formed and active. PubMed Central (PMC) (.gov) A1 (Active 1):

The ulcer is deep, covered with a thick white or yellow coating (slough), and the surrounding tissue (gastric wall) is significantly swollen and reddened. A2 (Active 2):

The ulcer remains active, but the surrounding swelling begins to decrease, and the edges of the ulcer become more defined. ClinicalTrials.gov 2. Healing Stage (H)

In this phase, the ulcer begins to shrink as new tissue (epithelium) starts to regrow. giresearch.ph H1 (Healing 1):

The coating at the base of the ulcer becomes thinner, and new regenerative tissue begins to grow inward from the edges, making the ulcer smaller. H2 (Healing 2):

The ulcer is very shallow and nearly covered by new tissue. The surrounding inflammation has largely disappeared. PubMed Central (PMC) (.gov) 3. Scarring Stage (S)

This is the final stage where the ulcer has completely closed, leaving only a scar behind. ClinicalTrials.gov S1 (Scarring 1/Red Scar):

The ulcer has disappeared, replaced by a red scar consisting of young, delicate tissue. S2 (Scarring 2/White Scar):

Over time, the red scar matures and turns white, indicating the final stage of complete healing. 臨床研究等提出・公開システム Summary Table Clinical Appearance Deep ulcer, thick slough, heavy swelling Defined ulcer edges, reduced swelling Thin slough, regenerative tissue growth Shallow ulcer, nearly healed Red scar (new tissue) White scar (mature tissue)

This system is essential for doctors to determine if a treatment (like proton pump inhibitors ) is working and to predict the risk of gastrointestinal bleeding or recurrence. giresearch.ph Forrest classification , which is used to assess the risk of active from these ulcers?

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sakita-Miwa classification (also known as the Sakita and Miwa scale) is

a widely used endoscopic staging system for assessing the life cycle and healing process of gastric ulcers . It categorizes ulcers into three main stages— Active (A) Healing (H) Scarring (S)

—with each stage further divided into two sub-stages for a total of six steps. PubMed Central (PMC) (.gov) Six Stages of Sakita-Miwa Classification Active Stage (A)

: The ulcer is deep with a thick white or yellow coating (slough). The surrounding mucosa is edematously swollen (swelling from fluid), and no regenerating epithelium (new skin) is visible.

: Swelling decreases, and the ulcer margin becomes clear. A small amount of regenerating epithelium may appear at the edges, often accompanied by a red "halo" or white "circle" around the margin. Healing Stage (H) Introduction The goal of any lesion classification is

: The white coating becomes thin, and new epithelium significantly extends into the ulcer base. The ulcer crater is still visible, but its diameter is reduced to about one-half or two-thirds of the A1 size.

: The ulcer defect is much smaller than H1. Regenerating epithelium covers most of the floor, and the white coating occupies only about a quarter to one-third of the original A1 area. Scarring Stage (S) S1 (Red Scar)

: The regenerating epithelium completely covers the ulcer floor, and the white coating has disappeared. The area appears markedly red due to many visible capillaries. S2 (White Scar)

: Over several months to years, the redness fades, and the scar becomes the same color as the surrounding mucosa, appearing as a white spot. Scoring System

In clinical research, these stages are sometimes assigned scores to quantify healing progress: : 5–6 points (most active) : 4–5 points : 3–4 points : 2–3 points : 1–2 points : 0–1 points (fully healed)

The Sakita-Miwa classification is a standardized medical staging system used primarily in East Asian clinical practice to evaluate the healing process of gastric and duodenal ulcers. It breaks down the "life cycle" of an ulcer into six distinct stages categorized under three main phases: Active, Healing, and Scarring. Active Phase (A)

This is the initial stage where the ulcer is fully formed and "open."

A1 (Active 1): The ulcer is at its peak. The surrounding mucosa (lining) is swollen and red, and the ulcer floor is covered with a thick "white coating" (slough).

A2 (Active 2): The swelling around the edges begins to subside, but the white coating remains thick and the ulcer crater is still very distinct. Healing Phase (H)

In this phase, the body begins to repair the damage and "fill in" the crater.

H1 (Healing 1): The ulcer crater is still visible, but the margins become sharper and the diameter of the defect shrinks to about half or two-thirds of the A1 stage. Regenerating epithelium (new skin) starts appearing at the edges.

H2 (Healing 2): The defect becomes much smaller. New regenerating epithelium covers most of the ulcer floor, though a small white coating may still be visible. Scarring Phase (S)

This is the final stage where the ulcer has effectively closed.

S1 (Scarring 1/Red Scar): The white coating has completely disappeared, and new epithelium fully covers the floor. Because the new tissue is thin and has many blood vessels, it appears as a "red scar".

S2 (Scarring 2/White Scar): Over several months to years, the redness fades. The scar becomes the same color as the surrounding tissue, often appearing as a "white scar".

💡 Clinical SignificanceDoctors use this system to determine if a treatment—like proton pump inhibitors (PPIs)—is working. An ulcer is medically considered "cured" once it reaches the S1 or S2 stage.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The Sakita-Miwa classification is a standard endoscopic staging system used to evaluate the healing process of gastric and duodenal ulcers. It divides ulcer progression into three main stages (Active, Healing, and Scarring), with each further subdivided into two levels. Classification Stages The system uses the following six-stage categorical scale: Stage Description A1 Acute phase; thick white coating (slough) and sharp edges. A2

Slough becomes thinner; regenerative epithelium begins to appear. H1

Significant reduction in slough; clear signs of marginal regeneration. H2 Ulcer becomes very small; slough is nearly gone. S1 Scarring 1 Red scar; the white coating has completely disappeared. S2 Scarring 2

White scar; the lesion is completely healed and mucosal folds normalize. Relevant Papers

The classification was originally established in the early 1970s. While the original primary text is often cited as a textbook or early Japanese journal entry, you can find the classification detailed and applied in these authoritative research papers:

Original/Reference Source: Sakita T, et al. "Endoscopic diagnosis of ulcer—Classification of the ulcer stage." Japan Journal of Gastroenterology (1971).

Modern Application: The value of oral contrast-enhanced gastric ultrasonography (OCUS) in the staging of benign peptic ulcer (BPU) published in Nature Scientific Reports (2024).

Clinical Efficacy Study: Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients published in Digestive Diseases (2011).

Comparative Trial: Randomised clinical trial: tegoprazan or lansoprazole in the treatment of gastric ulcer in Alimentary Pharmacology & Therapeutics (2020).

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

However, "Sakitamiwa" is not a standard term in modern Western medical literature (ICD-10 or ICD-11). It is most likely a folk illness concept or a traditional classification of symptoms.

Below is a developed academic paper proposal structured to explore this topic. This paper treats "Sakitamiwa" as a Folk Illness Syndrome, analyzing it through the lenses of medical anthropology and ethnomedicine.

Title: Beyond the Biomedical: An Ethnomedical Analysis of 'Sakitamiwa' Classification and its Socio-Cultural Determinants

Abstract This paper investigates the classification of "Sakitamiwa," a term rooted in local indigenous medical systems, often referenced in Southeast Asian ethnomedicine. While modern biomedicine categorizes illness based on pathology and etiology, folk classifications like Sakitamiwa rely on symptom clusters, social context, and spiritual etiology. This study aims to deconstruct the Sakitamiwa classification, comparing its nosology with Western biomedical frameworks. By analyzing the symptomatic presentation and traditional healing rituals associated with Sakitamiwa, this paper argues that such classifications serve as crucial cultural coping mechanisms, offering a holistic framework that addresses the biological, psychological, and social well-being of the patient.

Management Principles